Cited by 122Probiotics and Fermented FoodsNatural Antidiabetic Agents StudiesGut microbiota and health

Glucose- and glycaemic factor-lowering effects of probiotics on diabetes: A meta-analysis of randomised placebo-controlled trials

Open access
Sun, Jing, Buys, Nicholas J.·2016·British Journal of Nutrition

Abstract

This meta-analysis examined the effect of probiotics on glucose and glycaemic factors in diabetes and its associated risk factors. All randomised-controlled trials published in English in multiple databases from January 2000 to June 2015 were systematically searched. Only studies that addressed glucose- and glycaemic-related factors as outcome variables were included. The main outcomes of interest in trials were mean changes in glucose, HbA1c, insulin and homoeostasis model assessment-estimated insulin resistance (HOMA-IR). Using the Physiotherapy Evidence Database (PEDro) scale to assess the quality of studies, a total of eleven studies with 614 subjects were included. The pooled mean difference and effect size with a 95 % CI were extracted using a random-effect model. It was found that there are statistically significant pooled mean differences between the probiotics and the placebo-controlled groups on the reduction of glucose (−0·52 mmol/l, 95 % CI −0·92, −0·11 mmol/l; P=0·01) and HbA1c (−0·32 %, 95 % CI −0·57, −0·07 %; P=0·01). There was no statistically significant pooled mean difference between the probiotics and the placebo-controlled groups on the reduction of insulin (−0·48 µIU/ml, 95 % CI −1·34, 0·38 µIU/ml; P=0·27) and HOMA-IR (pooled effect of –0·44, 95 % CI −1·57, 0·70; P=0·45). Meta-regression analysis identified that probiotics had significant effects on reduction of glucose, HbA1c, insulin and HOMA-IR in participants with diabetes, but not in participants with other risk factors. The present meta-analysis suggested that probiotics may be used as an important dietary supplement in reducing the glucose metabolic factors associated with diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s0007114516000076

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The FAA policy permits special issuance of medical certification to some applicants who provide medical documentation from an endocrinologist about treatment history, accidents, and current status.

    “This policy permits special issuance of medical certification to some applicants who provide medical documentation of their history of treatment, accidents, and current medical status by an endocrinologist.”

    From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1694]

    The Inclusion criteria and Conclusions (pages unavailable) address probiotic trials and glucose metabolism, not aviation medical certification. Searches for FAA special issuance, endocrinologist documentation, and applicant medical history found no passage addressing the claimed policy. (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • In 2019, the Federal Aviation Administration outlined considerations for insulin-treated type 1 or type 2 diabetes with a CGM option.

    “Similarly, in 2019, the Federal Aviation Administration outlined considerations for insulin-treated T1D or T2D with a CGM option.”

    From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1694]

    The Discussion and Conclusions address probiotic supplementation and glucose metabolism, not aviation policy. Searches for the Federal Aviation Administration, a 2019 policy, and a continuous glucose monitoring option found no relevant passage in our copy (page numbers unavailable). (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • For FAA first- and second-class airman certification, CGM data is required, while third-class airmen may use a non-CGM protocol.

    “For first- and second-class airman certification, CGM data is a requirement, whereas third-class airmen may use non-CGM protocol.1694”

    From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1694]

    The Data extraction and quality assessment and Conclusions sections address probiotics and glucose metabolism, not airman certification. Searches for CGM requirements, first- and second-class certification, and a third-class non-CGM protocol found no relevant passage in our copy (page numbers unavailable). (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

6 of the 36 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Sun, J., & Buys, N. J.
Affiliations
Griffith University (AU)
Corresponding author
Sun, Jing
Venue
British Journal of Nutrition
Published
2016-02-22
Volume
115
Issue
7
Pages
1167-1177
ISSN
  • 0007-1145 (ISSN-L)
  • 1475-2662
OpenAlex
W2273827122
Cited by
122
References
36
Citations by year
2026: 1 · 2025: 4 · 2024: 7 · 2023: 10 · 2022: 15 · 2021: 16 · 2020: 20 · 2019: 15 · 2018: 16 · 2017: 12 · 2016: 6
FWCI
1.87
Type
journal article
Language
en
Open access
Locations
  • British Journal Of Nutrition (publishedVersion)
  • PubMed (publishedVersion)
  • Griffith Research Online (submittedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
probiotics, diabetes mellitus, blood glucose, HbA1c, insulin, insulin resistance, HOMA-IR, glycemic control, dietary supplements, diabetes risk factors
MeSH terms
Blood Glucose, Diabetes Mellitus, Fasting, Glycated Hemoglobin, Homeostasis, Humans, Insulin, Insulin Resistance, Placebos, Risk Factors, Randomized Controlled Trials as Topic, Dietary Supplements, Probiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review